These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16081793)

  • 21. Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4.
    Decker P; Le Moal A; Briand JP; Muller S
    J Immunol; 2000 Jul; 165(2):654-62. PubMed ID: 10878337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
    Nelson D; Bundell C; Robinson B
    J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of T-cell response to cryptic MHC determinants during allograft rejection.
    Boisgérault F; Anosova NG; Tam RC; Illigens BM; Fedoseyeva EV; Benichou G
    Hum Immunol; 2000 Dec; 61(12):1352-62. PubMed ID: 11163093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse.
    Penna G; Amuchastegui S; Cossetti C; Aquilano F; Mariani R; Giarratana N; De Carli E; Fibbi B; Adorini L
    J Immunol; 2007 Aug; 179(3):1559-67. PubMed ID: 17641022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice.
    Shih FF; Cerasoli DM; Caton AJ
    Int Immunol; 1997 Feb; 9(2):249-61. PubMed ID: 9040007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus.
    Talken BL; Schäfermeyer KR; Bailey CW; Lee DR; Hoffman RW
    J Immunol; 2001 Jul; 167(1):562-8. PubMed ID: 11418695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope.
    Dalum I; Jensen MR; Gregorius K; Thomasen CM; Elsner HI; Mouritsen S
    Mol Immunol; 1997; 34(16-17):1113-20. PubMed ID: 9566759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues.
    Moudgil KD; Grewal IS; Jensen PE; Sercarz EE
    J Exp Med; 1996 Feb; 183(2):535-46. PubMed ID: 8627165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
    Mo AX; van Lelyveld SF; Craiu A; Rock KL
    J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DM determines the cryptic and immunodominant fate of T cell epitopes.
    Nanda NK; Sant AJ
    J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice.
    Ercolini AM; Machiels JP; Chen YC; Slansky JE; Giedlen M; Reilly RT; Jaffee EM
    J Immunol; 2003 Apr; 170(8):4273-80. PubMed ID: 12682262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for immunodominance between closely related epitopes in the selection of T cell repertoire: hierarchy of T cell epitopes in a repeating sequence.
    Novak Z; Fraga E; Singh B
    Mol Immunol; 1992 Dec; 29(12):1467-76. PubMed ID: 1454065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.
    Qi L; Rojas JM; Ostrand-Rosenberg S
    J Immunol; 2000 Nov; 165(10):5451-61. PubMed ID: 11067897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: a single MHC anchor residue alters the conformation of a peptide-MHC complex inducing T cells that survive negative selection.
    Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
    J Immunol; 2001 May; 166(10):5874-7. PubMed ID: 11342600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Dermatophagoides pteronyssinus group 2 allergen contains a universally immunogenic T cell epitope.
    Wu B; Elst LV; Carlier V; Jacquemin MG; Saint-Remy JM
    J Immunol; 2002 Sep; 169(5):2430-5. PubMed ID: 12193711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation.
    Velazquez C; DiPaolo R; Unanue ER
    J Immunol; 2001 May; 166(9):5488-94. PubMed ID: 11313387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.